Results 91 to 100 of about 6,245 (175)

Comparing the impact of systemic pituitary adenylate-cyclase-activating polypeptide (PACAP) and calcitonin gene-related peptide (CGRP) on motion-induced nausea and balance behaviors in mice. [PDF]

PLoS One
Rahman SM, Dweh A, Luebke AE.
europepmc   +1 more source

Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms. [PDF]

Geroscience, 2022
Pham D, Polgar B, Toth T, Jungling A, Kovacs N, Balas I, Pal E, Szabo D, Fulop BD, Reglodi D, Szanto Z, Herczeg R, Gyenesei A, Tamas A.   +13 more
europepmc   +1 more source

Immunomodulation With Local, Sustained Delivery of Pituitary Adenylate Cyclase Activating Polypeptide Results in Improved Functional Recovery in Stroke-Injured Mice. [PDF]

Adv Healthc Mater
Ho E, Li DX, Cui H, Akbar D, Siu R, Morshead CM, Chatenet D, Shoichet MS.   +7 more
europepmc   +1 more source

Sex-related differences in endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) in the thalamic paraventricular nucleus: Implications for addiction neuroscience. [PDF]

Addict Neurosci, 2023
Curtis GR, Gargiulo AT, Carpenter BA, Pirino BE, Hawks A, Coleman SA, Syed NA, Gupta A, Barson JR.   +8 more
europepmc   +1 more source

Pituitary adenylate cyclase-activating polypeptide mediates bacterial endotoxin-induced fever via an effect on cyclooxygenase-2 and inflammatory cytokines. [PDF]

Sci Rep
Sparks J, Furedi N, Fekete K, Solymar M, Pohoczky K, Kemeny A, Reglodi D, Garami A, Pakai E.   +8 more
europepmc   +1 more source

Alterations in pituitary adenylate cyclase-activating polypeptide in major depressive disorder, bipolar disorder, and comorbid depression in Alzheimer's disease in the human hypothalamus and prefrontal cortex. [PDF]

Psychol Med, 2023
Slabe Z, Balesar RA, Verwer RWH, Van Heerikhuize JJ, Pechler GA, Zorović M, Hoogendijk WJG, Swaab DF.   +7 more
europepmc   +1 more source

Adenylate cyclase activating polypeptide pituitary (ADCYAP1; PACAP); adenylate cyclase activating polypeptide 1 pituitary receptor type I (ADCYAP1R1; PAC1) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Administration of a Selective Antagonist for Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat. [PDF]

Neuropsychopharmacol Rep
Sato K, Chiba S, Hatakeyama T, Matsuwaki T, Watanabe G, Kawaguchi M.   +5 more
europepmc   +1 more source

Spinal Astrocyte-Neuron Lactate Shuttle Contributes to the Pituitary Adenylate Cyclase-Activating Polypeptide/PAC1 Receptor-Induced Nociceptive Behaviors in Mice. [PDF]

Biomolecules, 2022
Kambe Y, Youkai M, Hashiguchi K, Sameshima Y, Takasaki I, Miyata A, Kurihara T.   +6 more
europepmc   +1 more source

Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models. [PDF]

Mol Psychiatry
Shintani Y, Hayata-Takano A, Takasaki I, Kurihara T, Miyata A, Yamano Y, Ikuta M, Takeshita R, Murata K, Oguri T, Asaka C, Nunomura K, Lin B, Nakagawa S, Okada T, Toyooka N, Takumi T, Ago Y, Takuma K, Hashimoto H.   +19 more
europepmc   +1 more source